Potential Therapeutic Candidates for Age-Related Macular Degeneration (AMD)
Aging contributes to the risk of development of ocular diseases including, but not limited to, Age-related Macular Degeneration (AMD) that is a leading cause of blindness in the United States as well as worldwide. Retinal aging, that contributes to AMD pathogenesis, is characterized by accumulation...
Main Author: | Sonali Nashine |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-09-01
|
Series: | Cells |
Subjects: | |
Online Access: | https://www.mdpi.com/2073-4409/10/9/2483 |
Similar Items
-
Experimental Models in Neovascular Age Related Macular Degeneration
by: Olivia Rastoin, et al.
Published: (2020-06-01) -
A Review of Completed and Ongoing Complement Inhibitor Trials for Geographic Atrophy Secondary to Age-Related Macular Degeneration
by: Omar A. Halawa, et al.
Published: (2021-06-01) -
Prevalence of insomnia and depression in patients with age-related macular degeneration
by: Elżbieta Nowak, et al.
Published: (2018-07-01) -
Age-Related Macular Degeneration Staging by Color Fundus Photography vs. Multimodal Imaging—Epidemiological Implications (<i>The Coimbra Eye Study—Report 6</i>)
by: Cláudia Farinha, et al.
Published: (2020-05-01) -
Microglia Contribution to the Regulation of the Retinal and Choroidal Vasculature in Age-Related Macular Degeneration
by: C. Henrique Alves, et al.
Published: (2020-05-01)